Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Learn about the credit cards that provide the best cash back and points potential. Unlock the rewards that suit your spending habits.
28,655 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
As Trump hosts world 80th birthday celebrations, the Strait of Hormuz remains closed and oil trades above $90, fuelin...
Mega-cap IPOs from SpaceX and Anthropic are approaching, potentially reshaping index fund rules and 401(k) allocation...
A 65-year-old planning to retire on Amelia Island with $970,000 faces two distinct paths: cash housing or a mortgage....
A new AI-driven forecast puts Solana on a trajectory to smash expectations by late 2026, driven by on-chain adoption ...
A landmark ruling reshapes how investors view the Fed's independence and policy credibility. This could translate int...
A sharp slide in South Korea's equities market sparks a broader risk-off wave, with Bitcoin and other crypto assets w...
A growing slice of retirees is looking at the EM Local Currency Bond ETF for a higher income stream. But currency swi...
A growing share of young workers juggle caregiving with early careers, and traditional retirement planning often miss...
A major March storm grounded more than 1,800 flights across the United States, snarling spring break travel and forci...
Barclays lifts Atlassian price target to $112, signaling growing confidence in the company’s ARR trajectory and enter...
The SEC signals a potential rulemaking push for onchain market structures and software apps, aiming to bring clarity ...